EGFR and lung adenocarcinoma: In a meta-analysis study in 2015 by Midha in lung adenocarcinomas, the overall EGFR mutation frequency in the Asian Pacific region was 64% in non-smokers against 33% in smokers, and this result was obtained by reviewing 20 studies.